Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001209191-22-042152

10% owner sold 60,000 shares at $0.89 ($53,400)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Venrock Healthcare Capital Partners II, L.P. 10% owner 2022-07-12 Sale −60,000 $0.89 $53,400 20,637,286 I
Open-market sales · 60,000 sh · avg $0.89 · $53,400
Loading xslF345X03/doc4.xml…